Skip to main content
logo
Catalyst Pharmaceuticals, Inc. (CPRX)
Jul 15, 2026 - CPRX was delisted (reason: acquired by Angelini Pharma)
31.49
0.00 (0.00%)
Inactive · Last trade price on Jul 15, 2026

Catalyst Pharmaceuticals Revenue

Catalyst Pharmaceuticals had revenue of $149.39M in the quarter ending March 31, 2026, with 5.63% growth. This brings the company's revenue in the last twelve months to $596.96M, up 11.65% year-over-year. In the year 2025, Catalyst Pharmaceuticals had annual revenue of $588.99M with 19.78% growth.

Revenue (ttm)
$596.96M
Revenue Growth
+11.65%
P/S Ratio
6.46
Revenue / Employee
$3,279,989
Employees
182
Market Cap
3.85B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025588.99M97.26M19.78%
Dec 31, 2024491.73M93.53M23.49%
Dec 31, 2023398.20M184.00M85.90%
Dec 31, 2022214.20M73.37M52.10%
Dec 31, 2021140.83M21.76M18.27%
Dec 31, 2020119.07M16.77M16.39%
Dec 31, 2019102.31M101.81M20,361.20%
Dec 31, 2018500.00K--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010488.96K--
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CPRX News

More News